Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

The Role of ZNF143 in Breast Cancer Cell Survival Through the NAD(P)H Quinone Dehydrogenase 1⁻p53⁻Beclin1 Axis Under Metabolic Stress.

Paek AR, Mun JY, Jo MJ, Choi H, Lee YJ, Cheong H, Myung JK, Hong DW, Park J, Kim KH, You HJ.

Cells. 2019 Mar 30;8(4). pii: E296. doi: 10.3390/cells8040296.

2.

Loss of zinc-finger protein 143 contributes to tumour progression by interleukin-8-CXCR axis in colon cancer.

Verma V, Paek AR, Choi BK, Hong EK, You HJ.

J Cell Mol Med. 2019 Apr 1. doi: 10.1111/jcmm.14290. [Epub ahead of print]

3.

Prediction of IDH1 Mutation Status in Glioblastoma Using Machine Learning Technique Based on Quantitative Radiomic Data.

Lee MH, Kim J, Kim ST, Shin HM, You HJ, Choi JW, Seol HJ, Nam DH, Lee JI, Kong DS.

World Neurosurg. 2019 Feb 5. pii: S1878-8750(19)30257-8. doi: 10.1016/j.wneu.2019.01.157. [Epub ahead of print]

PMID:
30735871
4.

Integrated molecular characterization of adult soft tissue sarcoma for therapeutic targets.

Kim J, Kim JH, Kang HG, Park SY, Yu JY, Lee EY, Oh SE, Kim YH, Yun T, Park C, Cho SY, You HJ.

BMC Med Genet. 2018 Dec 31;19(Suppl 1):216. doi: 10.1186/s12881-018-0722-6.

5.

Farnesyl diphosphate synthase is important for the maintenance of glioblastoma stemness.

Kim HY, Kim DK, Bae SH, Gwak H, Jeon JH, Kim JK, Lee BI, You HJ, Shin DH, Kim YH, Kim SY, Han SS, Shim JK, Lee JH, Kang SG, Jang H.

Exp Mol Med. 2018 Oct 17;50(10):137. doi: 10.1038/s12276-018-0166-2.

6.

BLT2, a leukotriene B4 receptor 2, as a novel prognostic biomarker of triple-negative breast cancer.

Park J, Jang JH, Park GS, Chung Y, You HJ, Kim JH.

BMB Rep. 2018 Aug;51(8):373-377. Review.

7.

Quantitative radiomic profiling of glioblastoma represents transcriptomic expression.

Kong DS, Kim J, Ryu G, You HJ, Sung JK, Han YH, Shin HM, Lee IH, Kim ST, Park CK, Choi SH, Choi JW, Seol HJ, Lee JI, Nam DH.

Oncotarget. 2018 Jan 5;9(5):6336-6345. doi: 10.18632/oncotarget.23975. eCollection 2018 Jan 19.

8.
9.

Migration and invasion of drug-resistant lung adenocarcinoma cells are dependent on mitochondrial activity.

Jeon JH, Kim DK, Shin Y, Kim HY, Song B, Lee EY, Kim JK, You HJ, Cheong H, Shin DH, Kim ST, Cheong JH, Kim SY, Jang H.

Exp Mol Med. 2016 Dec 9;48(12):e277. doi: 10.1038/emm.2016.129.

10.

Oncogenic function and clinical implications of SLC3A2-NRG1 fusion in invasive mucinous adenocarcinoma of the lung.

Shin DH, Lee D, Hong DW, Hong SH, Hwang JA, Lee BI, You HJ, Lee GK, Kim IH, Lee YS, Han JY.

Oncotarget. 2016 Oct 25;7(43):69450-69465. doi: 10.18632/oncotarget.11913.

11.

Integrative radiogenomic analysis for genomic signatures in glioblastomas presenting leptomeningeal dissemination.

You HJ, Park HY, Kim J, Lee IH, Seol HJ, Lee JI, Kim ST, Kong DS, Nam DH.

Medicine (Baltimore). 2016 Jul;95(27):e4109. doi: 10.1097/MD.0000000000004109.

12.

Regulation of cancer cell death by a novel compound, C604, in a c-Myc-overexpressing cellular environment.

Jo MJ, Paek AR, Choi JS, Ok CY, Jeong KC, Lim JH, Kim SH, You HJ.

Eur J Pharmacol. 2015 Dec 15;769:257-65. doi: 10.1016/j.ejphar.2015.11.027. Epub 2015 Nov 25.

PMID:
26607468
13.
14.

A role of zinc-finger protein 143 for cancer cell migration and invasion through ZEB1 and E-cadherin in colon cancer cells.

Paek AR, Lee CH, You HJ.

Mol Carcinog. 2014 Feb;53 Suppl 1:E161-8. doi: 10.1002/mc.22083. Epub 2013 Sep 5.

PMID:
24009065
15.

Transglutaminase-2 induces N-cadherin expression in TGF-β1-induced epithelial mesenchymal transition via c-Jun-N-terminal kinase activation by protein phosphatase 2A down-regulation.

Park MK, You HJ, Lee HJ, Kang JH, Oh SH, Kim SY, Lee CH.

Eur J Cancer. 2013 May;49(7):1692-705. doi: 10.1016/j.ejca.2012.11.036. Epub 2013 Jan 2.

PMID:
23290789
16.
17.
18.

Anti-atherogenic effect of BHB-TZD having inhibitory activities on cyclooxygenase and 5-lipoxygenase in hyperlipidemic mice.

Choi JH, Jeon HJ, Park JG, Sonn SK, Lee MR, Lee MN, You HJ, Kim GY, Kim JH, Lee MH, Kwon OS, Nam KH, Kim HC, Jeong TS, Lee WS, Oh GT.

Atherosclerosis. 2010 Sep;212(1):146-52. doi: 10.1016/j.atherosclerosis.2010.05.003. Epub 2010 May 11.

PMID:
20684827
19.

GIPC mediates the generation of reactive oxygen species and the regulation of cancer cell proliferation by insulin-like growth factor-1/IGF-1R signaling.

Choi JS, Paek AR, Kim SY, You HJ.

Cancer Lett. 2010 Aug 28;294(2):254-63. doi: 10.1016/j.canlet.2010.02.007. Epub 2010 Mar 4.

PMID:
20206441
20.

The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2.

You HJ, How T, Blobe GC.

Carcinogenesis. 2009 Aug;30(8):1281-7. doi: 10.1093/carcin/bgp071. Epub 2009 Mar 26.

Supplemental Content

Loading ...
Support Center